Screening diabetic patients at risk for foot ulceration. A multi-centre hospital-based study in France

Diabetes and Metabolism

Volumn 29, Issue 3, 2003, Pages 261-268

  Malgrange, D ^a   Richard, J L ^b   Leymarie, F ^c  

^a SERVICE DE DERMATOLOGIE   (France)

^b Centre Medical   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Classification; Diabetic foot ulcer; Risk factors; Screening

Indexed keywords

ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; CLINICAL EXAMINATION; DIABETES MELLITUS; DIABETIC FOOT; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; FOOT MALFORMATION; FOOT ULCER; FRANCE; HEALTH SURVEY; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; KIDNEY DISEASE; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OUTPATIENT; PREVALENCE; PROPHYLAXIS; QUALITY OF LIFE; RETINOPATHY; RISK FACTOR; SENSORY NEUROPATHY;

EID: 0038389432     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70035-6     Document Type: Article

References (33)

1. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care, 1999, 22, 382-7.
2. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care, 1998, 21, 2161-77.
3. Carpentier B, Pradines S, Benhamou PY, Halimi S. Coûts de santé liés aux lésions du pied chez les diabétiques dans les pays développés. Diabetes Metab, 2000, 26, 75-80.
4. Richard JL. Dépistage et prévention du pied diabétique à risque. In: Le Pied Diabétique. Richard JL, Vannereau D, eds. Paris: Editions M.F., 2002, 209-46.
5. Sims DS, Cavanagh PR, Ulbrecht JS. Risk factors in the diabetic foot. Recognition and management. Phys Ther, 1988, 68, 1887-902.
6. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med, 1998, 158, 157-62.
7. Peters EJG, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care, 2001, 24, 1442-7.
8. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower extremity amputation in a primary health care setting: a prospective evaluation of simple screening criteria. Diabetes Care, 1992, 15, 1389-92.
9. Abbott CA, Carrington AL, Ashe H, et al. The North-West Foot Care Study: incidence of, and risk factors for new diabetic foot ulceration in a community-based patient cohort. Diabet Med, 2002, 5, 377-84.
10. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med, 1993, 233, 485-91.
11. McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care, 1995, 18, 216-9.
12. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care, 1999, 22, 1036-42.
13. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration. Diabetes Care, 2000, 23, 606-11.
14. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care, 1997, 20, 1273-8.
15. Veves A, Murray HJ, Young MJ, Boulton AMJ. The risk of foot ulceration in diabetic patients with high pressure: a prospective study. Diabetologia, 1992, 35, 660-3.
16. Sriussadaporn S, Mekanandha P, Vannasaeng S, et al. Factors associated with diabetic foot ulceration in Thailand: a case-control study. Diabet Med, 1997, 14, 50-6.
17. Fernando DJS, Hutchison A, Veves A, Gokal R, Boulton AJM. Risk factors for non-ischaemic foot ulceration in diabetic nephropathy. Diabet Med, 1991, 8, 223-5.
18. Vileikyte L, Shaw JE, Kincey J, Carrington AL, Abbott C, Boulton AJM. A prospective study of neuropathic and psychological factors in foot ulceration. Diabetologia, 1996, 39, A3 [Abstract].
19. Apelqvist J, Bakker K, Van Houtum WH, Nabuurs-Fransen MH, Schaper NC. International consensus on the diabetic foot. In The International Working Group on the Diabetic Foot. Amsterdam: John Wiley & Sons, 1999, 66-7.
20. Apelqvist J, Bakker K, Van Houtum WH, Nabuurs-Fransen MH, Schaper NC. International consensus practical guidelines on the management and prevention of the diabetic foot. Diabetes Metab Res Rey, 2000, 16, S84-92.
21. Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES). Suivi du patient diabétique de type 2 à l'exclusion du suivi des complications. Diabetes Metab, 1999, 25, 1-64.
22. Kumar S, Ashe HA, Parnell LN, et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med, 1994, 11, 480-4.
23. Letho S, Rönnemaa T, Pyörälä K, Laakso M. Risk factors predicting lower extremity amputation in patients with NIDDM. Diabetes Care, 1996, 19, 607-12.
24. De Heus-van Putten MA, Schaper NC, Bakker K. The clinical examination of the diabetic foot in clinical practice. Diabet Med, 1996, 13, S55-7.
25. Richard JL, Parer-Richard C. Le pied diabétique: données épidémiologiques et économiques. In: Le Pied Diabétique. Richard JL, Vannereau D, eds. Paris: Editions M.F., 2002, 23-40.
26. Kumar S, Fernando DJS, Veves A, Knowles EA, Young MJ, Boulton AJM. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract, 1991, 13, 63-8.
27. Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care, 2000, 23, 984-8.
28. McGill M, Molyneaux L, Yue DK. Use of the Semmes-Weinstein 5.07/10 g monofilament: the long and the short of it. Diabet Med, 1998, 15, 615-7.
29. Ahroni JH, Boyko EJ, Forberg RC. Clinicil correlates of plantar pressure among diabetic veterans. Diabetes Care, 1999, 22, 965-72.
30. Murray HJ, Young MJ, Hollis S, Boulton AJM. The association between callus formation, high pressure and neuropathy in diabetic foot ulceration. Diabet Med, 1996, 13, 979-82.
31. Holewski JJ, Moss KM, Stess RM, Graf PM, Grunfeld C. Prevalence of foot pathology and lower extremity complications in a diabetic outpatient clinic. J Rehabil Res Dev, 1989, 26, 35-44.
32. Borssén B, Bergenheim T, Lithner F. The epidemiology of foot lesions in diabetic patients aged 15-50 years. Diabet Med, 1990, 7, 438-44.
33. Walters DP, Gatling W, Mullee MA, Hill RD. The distribution and severity of diabetic foot disease: a community study with a comparison to a non-diabetic group. Diabet Med, 1992, 9, 354-8.